Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: the randomized, double-blind, phase 3 ENGOT-Cx11/GOG-3047/KEYNOTE-A18 study

被引：2

作者：

Lorusso, Domenica ^{[1
,2
]}

Xiang, Yang ^{[3
]}

Hasegawa, Kosei ^{[4
]}

Scambia, Giovanni ^{[2
,5
]}

Leiva, Manuel ^{[6
]}

Ramos-Elias, Pier ^{[7
]}

Acevedo, Alejandro ^{[8
]}

Vizkeleti, Julia ^{[9
]}

Gomes, Andrea ^{[10
]}

Mejia, Fernando Contreras ^{[11
]}

Reiss, Ari ^{[12
]}

Ayhan, Ali ^{[13
]}

Lee, Jung-Yun ^{[14
]}

Saevets, Valeriya ^{[15
]}

Zagouri, Flora ^{[16
]}

Li, Kan ^{[17
]}

Yamada, Karin ^{[17
]}

Toker, Sarper ^{[17
]}

Pignata, Sandro ^{[18
]}

Duska, Linda R. ^{[19
]}

机构：

[1] Fdn Policlin Univ Gemelli IRCCS, Gynaecol Oncol Unit, Rome, Italy

[2] Univ Cattolica Sacro Cuore, Rome, Italy

[3] Peking Union Med Coll Hosp, Natl Clin Res Ctr Obstet & Gynecol Dis, Dept Obstet & Gynecol, Beijing, Peoples R China

[4] Saitama Med Univ, Int Med Ctr, Hidaka, Saitama, Japan

[5] Fdn Policlin Univ Agostino Gemelli IRCCS, Sci Directorate, Rome, Italy

[6] Inst Oncol & Radioterapia Clin Ricardo Palma, Lima, Peru

[7] Integra Canc Inst, Edificio Integra Med Ctr, Guatemala City, Guatemala

[8] Oncocentro, Valparaiso, Chile

[9] Natl Inst Oncol, Ctr Radiotherapy, Budapest, Hungary

[10] Liga Norte Riograndense Canc, Currais Novos, RN, Brazil

[11] Inst Nacl Cancerol, Bogota, Colombia

[12] Rambam Med Ctr, Gyneco Oncol Unit, Haifa, Israel

[13] Baskent Univ, Turkish Soc Gynecol Oncol TRSGO, Ankara, Turkiye

[14] Yonsei Univ, Severance Hosp, Coll Med, Seoul, South Korea

[15] Chelyabinsk Reg Clin Ctr Oncol & Nucl Med, Chelyabinsk, Russia

[16] Alexandra Hosp, Athens, Greece

[17] Merck & Co Inc, Rahway, NJ USA

[18] Ist Nazl Tumori IRCCS Fdn G Pascale, Dept Urol & Gynecol, Naples, Italy

[19] Univ Virginia, Sch Med, Charlottesville, VA USA

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_1期

关键词：

D O I：

10.1136/ijgc-2024-ESGO.3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

161

引用

页码：A2 / A2

页数：1